Premium
Experience with fetal nuchal translucency in a private clinic in São Paulo
Author(s) -
Cha S. C.,
Chinen P. A.,
Pares D.
Publication year - 2001
Publication title -
ultrasound in obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.202
H-Index - 141
eISSN - 1469-0705
pISSN - 0960-7692
DOI - 10.1046/j.1469-0705.2001.abs26-18.x
Subject(s) - medicine , abortion , fetus , hypoplasia , obstetrics , nuchal translucency , gynecology , ventricle , fetal death , first trimester , pregnancy , surgery , genetics , biology
The fetal nuchal translucency (NT) has been used since 1995 as screening exam for abnormal karyo‐type and structural malformations. Fetal nuchal translucency measurements were performed in 1877 pregnancies, during the period from 1995 to 2000, between 11 weeks to 13 weeks and 6 days. From the 1877 exams, we obtained 29 (1.4%) with abnormal NT and these data are the object of our study. Nineteen pregnancies (65.5%) had no structural malformation and/or karyo‐type abnormalities. We had one (3.4%) case of congenital heart disease with hypoplasia of left ventricle (death in the third day of life), one (3.4%) case of fetal dead for true knots of the cord, without other morphological disturb. Others three (10.3%) cases had spontaneous abortion (one case of 46 XX; one case of 69 XXY and the other case does not have karyo‐type). In two (6.9%) cases induced abortion happened, without karyo‐type study.